Skip to content
Chromogenics
The performance glass pioneers
ChromogenicsChromogenics
  • Products
    • Dynamic Glass
      • Control system
      • Technology
    • Colored Solar Facades
    • Static Glass
    • Services
  • Cases
  • Environment & Quality
    • Environment
    • Quality
  • News & press
    • News
    • Press Releases
  • About us
    • Career
    • Contact
    • Invoicing
    • Presentations
    • Sputter Factory
  • For Investors
  • Swedish
  • English
Search:
  • Products
    • Dynamic Glass
      • Control system
      • Technology
    • Colored Solar Facades
    • Static Glass
    • Services
  • Cases
  • Environment & Quality
    • Environment
    • Quality
  • News & press
    • News
    • Press Releases
  • About us
    • Career
    • Contact
    • Invoicing
    • Presentations
    • Sputter Factory
  • For Investors

ChromoGenics to the stock market

ChromoGenics AB (publ) is applying for listing of the Company’s shares and warrants (TO1) at Nasdaq First North.
Subscription period: 9th – 24th of February 2017
Liquidation: around March 6, 2017
Listing: around March 23, 2017

Briefly about ChromoGenics:

ChromoGenics is a global leader within dynamic glas with controllable, optical solutions. The Company’s unique electrochromic technology, ConverLight™, provides dynamic solar control with improved indoor comfort and energy efficiency. In 2016, sales and deliveries to real estate projects in Scandinavia began.

The demand for dynamic glas is driven by, among other factors, an increased focus on sustainability. Market research indicates that the market for dynamic glas will increase drastically over the next couple of years due to energy efficiency issues. ChromoGenics is based in Uppsala and derived from world-leading research at the Ångström laboratory at Uppsala University. The Company has approximately 20 employees.

Download the information brochure here
Download the prospectus here
Download the additional prospectus here

Download the application form here
Download the press release about IPO here

Documents available for inspection

The following documents are available for inspection at the Company’s office (Ullforsgatan 15, 752 28 Uppsala) as well as in electronic form at the Company’s website (www.chromogenics.com):

  • Articles of association of ChromoGenics AB (publ)
  • Prospectus
  • ChromoGenics AB (publ) reviewed financial interim information for the period January-September 2016
  • ChromoGenics AB (publ) audited accounts for the financial year of 2014, including the auditor’s report
  • ChromoGenics AB (publ) audited accounts for the financial year of 2015, including the auditor’s report

Documents incorporated by reference

The company’s annual reports have been prepared in accordance with the Annual Accounts Act (1995:1554) and The Swedish Accounting Standards Board’s general advice BFNAR 2012:1 (K3), and has been audited by the Company’s auditor. The audit reports for the annual reports of 2014 and 2015 are found on the last page of each annual report and are incorporated in their entirety by reference and form a part of the Prospectus. The financial interim information for 2016 has been established according to the same principles and regulations. The financial interim information has been reviewed by the Company’s auditor. The Company’s interim information for January – September 2016, including the audit report, is incorporated by reference and forms a part of the Prospectus. Below is a reference to the specific documents and pages:

  • The financial interim information for the period January – September 2016. The income statement and balance sheet can be found on pages 9 and 10 in the interim financial information, as well as the audit report on page 7.
  • The Company’s annual report for the financial year 2015, the income statement (page 6), balance sheet (pages 7-8), note 16 over changes in equity (page 20), accounting principles and disclosures in notes (pages 9-22) together with the audit report (last page).
  • The Company’s annual report for the financial year 2014, the income statement (page 6), balance sheet (pages 7-8), note 15 over changes in equity (page 20), accounting principles and disclosures in notes (pages 9-22) together with the audit report (last page).

Link to nordnet:

Nordnet logo, black and light blue

Link for customers at Skandiabanken:

Skandiabanken green logo

Link to Avanza:
Log in to your account and select My pages/New issues & Introductions/Other Offers

Avanza logo, black and green

Others subscribe via Aktieinvest (also with bank ID).

Subscribe for shares in ChromoGenics

Contact us

For Investors

Financial Calendar

Financial Reports

  • Interim Reports
  • Annual Reports

Presentations

Press Releases

Corporate Governance

  • General Meetings
  • Articles of Association
  • Board of Directors
  • Management
  • Nomination Committee
  • Auditor
  • Certified Adviser

Share Information

Rights Issues

  • Rights Issue 2022 February – March
  • Rights Issue 2020 November – December
  • Rights Issue 2020 February – March
  • Rights Issue 2019 June – July
  • Rights Issue 2019 January – February
  • Rights Issue 2018

IPO

Glossary

IR Contact
Black and white profil picture of Lars Ericsson, CFO & Head of Communications at ChromoGenics
Lars Ericsson

CFO & Head of Communications

+46 70 549 76 44lars.ericsson@chromogenics.com
Follow us

Follow us on social media to stay updated on what´s happening at ChromoGenics

ChromoGenicswhitelogo
  • Swedish
  • English
Contact

info@chromogenics.com

+46 18 430 04 30

Ullforsgatan 15

SE-75228 Uppsala, Sweden
ChromoGenics
  • About us
  • Contact
  • ConverLight
  • For Investors
  • Press Releases
Follow us

Find us on:

Facebook page opens in new windowTwitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
Chromogenics
© ChromoGenics 2022 | Cookies & Privacy Notice
Go to Top
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Read More Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
SAVE & ACCEPT